178 related articles for article (PubMed ID: 30660566)
1. The anticancer properties and mechanism of action of tablysin-15, the RGD-containing disintegrin, in breast cancer cells.
Deng Z; Chai J; Zeng Q; Zhang B; Ye T; Chen X; Xu X
Int J Biol Macromol; 2019 May; 129():1155-1167. PubMed ID: 30660566
[TBL] [Abstract][Full Text] [Related]
2. Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling.
Deng Z; Zeng Q; Chai J; Zhang B; Zheng W; Xu X; Wu J
Curr Cancer Drug Targets; 2020; 20(4):306-315. PubMed ID: 31893992
[TBL] [Abstract][Full Text] [Related]
3. A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis.
Ma D; Xu X; An S; Liu H; Yang X; Andersen JF; Wang Y; Tokumasu F; Ribeiro JM; Francischetti IM; Lai R
Thromb Haemost; 2011 Jun; 105(6):1032-45. PubMed ID: 21475772
[TBL] [Abstract][Full Text] [Related]
4. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
[TBL] [Abstract][Full Text] [Related]
5. Tablysin-15 inhibits osteoclastogenesis and LPS-induced bone loss via attenuating the integrin α
Zeng Q; Lu W; Deng Z; Wu J; Guo R; Xu X
Chem Biol Interact; 2020 Aug; 327():109179. PubMed ID: 32534990
[TBL] [Abstract][Full Text] [Related]
6. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
7. β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer.
Gao M; Dang F; Deng C
Eur J Pharmacol; 2019 Sep; 859():172528. PubMed ID: 31288004
[TBL] [Abstract][Full Text] [Related]
8. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
9. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
[TBL] [Abstract][Full Text] [Related]
10. ABT-263 induces G
Lin QH; Que FC; Gu CP; Zhong DS; Zhou D; Kong Y; Yu L; Liu SW
Acta Pharmacol Sin; 2017 Dec; 38(12):1632-1641. PubMed ID: 28713162
[TBL] [Abstract][Full Text] [Related]
11. Disintegrin targeting of an αvβ3 integrin-over-expressing high-metastatic human osteosarcoma with echistatin inhibits cell proliferation, migration, invasion and adhesion in vitro.
Tome Y; Kimura H; Kiyuna T; Sugimoto N; Tsuchiya H; Kanaya F; Bouvet M; Hoffman RM
Oncotarget; 2016 Jul; 7(29):46315-46320. PubMed ID: 27331872
[TBL] [Abstract][Full Text] [Related]
12. Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells.
Gao X; Han L; Ding N; Mu Y; Guan P; Hu C; Huang X
J Antibiot (Tokyo); 2018 Sep; 71(9):808-817. PubMed ID: 29752478
[TBL] [Abstract][Full Text] [Related]
13. Study of the antitumor mechanisms of apiole derivatives (AP-02) from Petroselinum crispum through induction of G0/G1 phase cell cycle arrest in human COLO 205 cancer cells.
Wu KH; Lee WJ; Cheng TC; Chang HW; Chen LC; Chen CC; Lien HM; Lin TN; Ho YS
BMC Complement Altern Med; 2019 Jul; 19(1):188. PubMed ID: 31351461
[TBL] [Abstract][Full Text] [Related]
14. The disintegrin, trimucrin, suppresses LPS-induced activation of phagocytes primarily through blockade of NF-κB and MAPK activation.
Hung YC; Hsu CC; Chung CH; Huang TF
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):723-37. PubMed ID: 27030393
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.
Hu H; Dong Z; Tan P; Zhang Y; Liu L; Yang L; Liu Y; Cui H
Oncotarget; 2016 Jan; 7(3):3171-85. PubMed ID: 26621850
[TBL] [Abstract][Full Text] [Related]
16. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
[TBL] [Abstract][Full Text] [Related]
17. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL
Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097
[TBL] [Abstract][Full Text] [Related]
18. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
19. A novel alpha(v)beta (3)-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis.
Ramos OH; Kauskot A; Cominetti MR; Bechyne I; Salla Pontes CL; Chareyre F; Manent J; Vassy R; Giovannini M; Legrand C; Selistre-de-Araujo HS; Crépin M; Bonnefoy A
Clin Exp Metastasis; 2008; 25(1):53-64. PubMed ID: 17952617
[TBL] [Abstract][Full Text] [Related]
20. The Effects of αvβ3 Integrin Blockage in Breast Tumor and Endothelial Cells under Hypoxia In Vitro.
Casali BC; Gozzer LT; Baptista MP; Altei WF; Selistre-de-Araújo HS
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
